A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 23,241 shares of MRK stock, worth $2.24 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
23,241
Previous 22,879 1.58%
Holding current value
$2.24 Million
Previous $2.83 Million 6.81%
% of portfolio
0.55%
Previous 0.65%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$111.15 - $128.97 $40,236 - $46,687
362 Added 1.58%
23,241 $2.64 Million
Q2 2024

Jul 31, 2024

BUY
$123.8 - $132.96 $21,541 - $23,135
174 Added 0.77%
22,879 $2.83 Million
Q1 2024

May 01, 2024

SELL
$113.24 - $131.95 $23,667 - $27,577
-209 Reduced 0.91%
22,705 $3 Million
Q4 2023

Feb 05, 2024

SELL
$100.18 - $109.02 $22,239 - $24,202
-222 Reduced 0.96%
22,914 $2.5 Million
Q3 2023

Oct 20, 2023

BUY
$102.95 - $114.33 $64,755 - $71,913
629 Added 2.79%
23,136 $2.38 Million
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $12,272 - $13,376
-113 Reduced 0.5%
22,507 $2.6 Million
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $12,764 - $14,242
124 Added 0.55%
22,620 $2.41 Million
Q4 2022

Feb 03, 2023

BUY
$87.44 - $112.11 $56,923 - $72,983
651 Added 2.98%
22,496 $2.5 Million
Q3 2022

Nov 07, 2022

BUY
$84.53 - $94.96 $201,012 - $225,814
2,378 Added 12.22%
21,845 $1.88 Million
Q2 2022

Nov 18, 2022

SELL
$83.49 - $94.64 $198,539 - $225,053
-2,378 Reduced 10.89%
19,467 $1.78 Million
Q2 2022

Jul 19, 2022

BUY
$83.49 - $94.64 $13,942 - $15,804
167 Added 0.87%
19,467 $1.78 Million
Q1 2022

Apr 26, 2022

BUY
$73.51 - $82.4 $23,008 - $25,791
313 Added 1.65%
19,300 $1.58 Million
Q4 2021

Feb 02, 2022

BUY
$72.28 - $90.54 $60,353 - $75,600
835 Added 4.6%
18,987 $1.46 Million
Q3 2021

Nov 08, 2021

BUY
$71.68 - $78.83 $9,318 - $10,247
130 Added 0.72%
18,152 $1.36 Million
Q2 2021

Nov 08, 2021

BUY
$70.31 - $77.77 $7,804 - $8,632
111 Added 0.62%
18,022 $1.4 Million
Q2 2021

Aug 03, 2021

BUY
$70.31 - $77.77 $56,388 - $62,371
802 Added 4.69%
17,911 $1.39 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $27,061 - $31,876
393 Added 2.35%
17,109 $1.32 Million
Q4 2020

Feb 08, 2021

SELL
$71.77 - $79.65 $1,578 - $1,752
-22 Reduced 0.13%
16,716 $1.37 Million
Q3 2020

Oct 27, 2020

BUY
$73.18 - $82.95 $52,177 - $59,143
713 Added 4.45%
16,738 $1.39 Million
Q2 2020

Jul 17, 2020

BUY
$70.42 - $80.13 $220,414 - $250,806
3,130 Added 24.27%
16,025 $1.24 Million
Q1 2020

Apr 08, 2020

BUY
$63.36 - $87.82 $85,789 - $118,908
1,354 Added 11.73%
12,895 $992,000
Q4 2019

Jan 08, 2020

SELL
$77.58 - $87.54 $35,376 - $39,918
-456 Reduced 3.8%
11,541 $1.05 Million
Q3 2019

Oct 08, 2019

SELL
$76.08 - $82.93 $16,965 - $18,493
-223 Reduced 1.82%
11,997 $1.01 Million
Q2 2019

Jul 09, 2019

SELL
$69.84 - $81.59 $15,714 - $18,357
-225 Reduced 1.81%
12,220 $1.03 Million
Q1 2019

Apr 11, 2019

BUY
$69.58 - $79.36 $30,963 - $35,315
445 Added 3.71%
12,445 $1.04 Million
Q4 2018

Jan 10, 2019

SELL
$65.24 - $75.71 $4,566 - $5,299
-70 Reduced 0.58%
12,000 $917,000
Q3 2018

Oct 09, 2018

BUY
$57.69 - $67.84 $32,479 - $38,193
563 Added 4.89%
12,070 $856,000
Q2 2018

Jul 13, 2018

SELL
$50.83 - $59.72 $9,149 - $10,749
-180 Reduced 1.54%
11,507 $698,000
Q1 2018

Apr 16, 2018

BUY
$50.96 - $59.23 $15,338 - $17,828
301 Added 2.64%
11,687 $637,000
Q4 2017

Jan 12, 2018

SELL
$51.62 - $61.64 $74,900 - $89,439
-1,451 Reduced 11.3%
11,386 $641,000
Q3 2017

Oct 12, 2017

BUY
$58.67 - $63.13 $753,146 - $810,399
12,837
12,837 $822,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $245B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Mitchell Mcleod Pugh & Williams Inc Portfolio

Follow Mitchell Mcleod Pugh & Williams Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.